Association between type of BRCA1/2 pathogenic/likely pathogenic variants and outcome in young patients with breast cancer: Results from an international cohort study. This is an ASCO Meeting Abstract ...
Lenvatinib and pembrolizumab in patients with metastatic papillary renal cell carcinoma: A phase 2 pilot study. Differences in the expression heterogeneity of ADC-related markers between primary ...